Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 4(65), 2021

DOI: 10.1128/aac.01539-20

Links

Tools

Export citation

Search in Google Scholar

Parasite-host dynamics throughout antimalarial drug development stages complicate the translation of parasite clearance

Journal article published in 2021 by Lydia Burgert, Sophie Zaloumis ORCID, Saber Dini ORCID, Louise Marquart, Pengxing Cao, Mohammed Cherkaoui, Nathalie Gobeau, James McCarthy ORCID, Julie A. Simpson, Jörg J. Möhrle ORCID, Melissa A. Penny ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Ensuring continued success against malaria depends on a pipeline of new antimalarials. Antimalarial drug development utilizes preclinical murine and experimental human malaria infection studies to evaluate drug efficacy.